✦ LIBER ✦

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

✍ Scribed by Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxin Lin; Arvind Shah; Robert S. Lowe; Mary E. Hanson; Andrew M. Tershakovec

Book ID: 119288061
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 469 KB
Volume: 5
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2011.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Ezetimibe Added to Atorvastat

Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk

✍ Christian Constance; Ori Ben-Yehuda; Nanette K. Wenger; Franklin Zieve; Jianxin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 50 KB

Age, Abdominal Obesity, and Baseline Hig

Age, Abdominal Obesity, and Baseline High-Sensitivity C-Reactive Protein Are Associated with Low-Density Lipoprotein Cholesterol, non–High-Density Lipoprotein Cholesterol, and ApoB Responses to Lipid-Lowering Therapy in Patients with Metabolic Syndrome and Moderately High/High Coronary Heart Disease Risk†

✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa A. Hsueh; Jeffery B. Rosen; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 63 KB